NCT05172544View on ClinicalTrials.gov

Trial of an Inactivated Yellow Fever Virus Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 13, 2022

Primary Completion Date

April 24, 2023

Study Completion Date

April 24, 2023

Conditions
Yellow Fever
Interventions
BIOLOGICAL

HydroVax-002 YFV

Inactivated YFV vaccine

OTHER

Placebo

NaCl 0.9%, Normal Saline

Trial Locations (1)

27705

Duke University Health System, Durham

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Najit Technologies, Inc.

INDUSTRY

NCT05172544 - Trial of an Inactivated Yellow Fever Virus Vaccine | Biotech Hunter | Biotech Hunter